Clinical Trials List
2024-01-26 - 2029-02-28
Phase III
Recruiting5
ICD-10C61
Malignant neoplasm of prostate
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9185
Malignant neoplasm of prostate
-
Trial Applicant
BAYER TAIWAN COMPANY LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王嘉儁 無
- PO-MING CHOW 無
- - - 無
- 闕士傑 無
- Chia-Hsien Chen 無
- JIAN-HUA HONG 無
- CHING-CHU LU 無
- 呂紹綸 無
- CHUNG-HSIN CHEN 無
- 藍耿學 無
- YU-CHUAN LU 無
- 張晉誠 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Chang Lin 無
- 張境夫 無
- 黃文冠 無
- 王翔生 無
- Hong-Cheng Gan 無
- PO-HUNG LIN 無
- Rita cheng 無
- 黃亮鋼 無
- 吳俊德 無
- 張鈞弼 無
- Po-Jung Su 無
- Kung-Chu Ho 無
- I-hung Shao 無
- Jing-Ren Tseng 無
- Kai-Jie Yu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
970 participants
